Seer, Inc.
SEERNasdaqHealthcare · Laboratory Analytical Instruments · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $16.6M | $14.2M | $16.7M | $15.5M | $6.6M | $656,000 |
| Operating income | −$78.0M | −$100.1M | −$103.5M | −$97.2M | −$71.5M | −$33.6M |
| Net income | −$73.6M | −$86.6M | −$86.3M | −$93.0M | −$71.2M | −$32.8M |
| Total assets | $296.1M | $366.6M | $436.3M | $487.9M | $539.1M | $442.3M |
| Total liabilities | $36.8M | $39.0M | $39.4M | $40.9M | $36.2M | $10.7M |
| Equity | $259.3M | $327.6M | $396.9M | $447.0M | $502.9M | $431.6M |
| EPS (diluted) | — | — | $-1.35 | $-1.49 | $-1.17 | $-2.48 |
| Shares out. | — | — | 63.9M | 63.4M | 62.0M | 59.3M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −470.5%
- Net margin
- −444.0%
- Return on equity
- −28.4%
- Return on assets
- −24.9%
- Return on capital (ROCE)
- −27.8%
- Liabilities / assets
- 12.4%
- Debt / equity
- 0.14×
- Book value / share
- —
- Revenue growth (YoY)
- 17.0%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- 4.62safe
- Accruals / assets
- −9.8%clean
- Piotroski F-Score
- 3/8weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 3 warning● 4 good- Operating losses (negative operating margin)
- Reported a net loss
- Negative operating cash flow
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Farokhzad OmidPassive (13G)May 15, 2026
- Invus Global Management, LlcPassive (13G)May 4, 2026
- Radoff Bradley LouisActivist (13D)Apr 13, 2026
- Schindel Yair ChaimPassive (13G)Jan 8, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 453,019 | 1.1 | +5.9% |
| Apr 30, 2026 | 427,617 | 1.0 | -1.1% |
| Apr 15, 2026 | 432,590 | 1.0 | -41.0% |
| Mar 31, 2026 | 732,581 | 4.3 | -5.4% |
| Mar 13, 2026 | 774,578 | 2.1 | -14.4% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Other material eventMay 22, 2026
- Results of operationsMay 13, 2026
- Other material eventMay 4, 2026
- Other material eventApr 27, 2026
- Other material eventApr 13, 2026
- Other material eventMar 30, 2026
- Entered a material agreement · Modified shareholder rightsMar 16, 2026
- Entered a material agreement · Modified shareholder rights · Amended charter or bylaws · Regulation FD disclosureFeb 26, 2026
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.